JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M408929200 on August 11, 2004

J. Biol. Chem., Vol. 279, Issue 43, 44483-44489, October 22, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/43/44483    most recent
M408929200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Capsazepine Is a Novel Activator of the {delta} Subunit of the Human Epithelial Na+ Channel*

Hisao Yamamura{ddagger}§, Shinya Ugawa{ddagger}, Takashi Ueda{ddagger}, Masataka Nagao¶, and Shoichi Shimada{ddagger}

From the {ddagger}Department of Molecular Morphology and Department of Forensic Medical Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan

The amiloride-sensitive epithelial Na+ channel (ENaC) regulates Na+ homeostasis into cells and across epithelia. So far, four homologous subunits of mammalian ENaC have been isolated and are denoted as {alpha}, {beta}, {gamma}, and {delta}. The chemical agents acting on ENaC are, however, largely unknown, except for amiloride and benzamil as ENaC inhibitors. In particular, there are no agonists currently known that are selective for ENaC{delta}, which is mainly expressed in the brain. Here we demonstrate that capsazepine, a competitive antagonist for transient receptor potential vanilloid subfamily 1, potentiates the activity of human ENaC{delta}{beta}{gamma} (hENaC{delta}{beta}{gamma}) heteromultimer expressed in Xenopus oocytes. The inward currents at a holding potential of –60 mV in hENaC{delta}{beta}{gamma}-expressing oocytes were markedly enhanced by the application of capsazepine (≥1 µM), and the capsazepine-induced current was mostly abolished by the addition of 100 µM amiloride. The stimulatory effects of capsazepine on the inward current were concentration-dependent with an EC50 value of 8 µM. Neither the application of other vanilloid compounds (capsaicin, resiniferatoxin, and olvanil) nor a structurally related compound (dopamine) modulated the inward current. Although hENaC{delta} homomer was also significantly activated by capsazepine, unexpectedly, capsazepine had no effect on hENaC{alpha} and caused a slight decrease on the hENaC{alpha}{beta}{gamma} current. In conclusion, capsazepine acts on ENaC{delta} and acts together with protons. Other vanilloids tested do not have any effect. These findings identify capsazepine as the first known chemical activator of ENaC{delta}.


Received for publication, August 4, 2004 , and in revised form, August 9, 2004.

* This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Sciences (to H. Y. and S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Molecular Morphology, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi Mizuhocho Mizuhoku, Nagoya 467-8601, Japan. Tel.: 81-52-853-8126; Fax: 81-52-852-8887; E-mail: yamamura{at}med.nagoya-cu.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Yamamura, S. Ugawa, T. Ueda, A. Morita, and S. Shimada
TRPM8 activation suppresses cellular viability in human melanoma
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C296 - C301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lu, F. Echeverri, D. Kalabat, B. Laita, D. S. Dahan, R. D. Smith, H. Xu, L. Staszewski, J. Yamamoto, J. Ling, et al.
Small Molecule Activator of the Human Epithelial Sodium Channel
J. Biol. Chem., May 2, 2008; 283(18): 11981 - 11994.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Yamamura, S. Ugawa, T. Ueda, and S. Shimada
Evans Blue Is a Specific Antagonist of the Human Epithelial Na+ Channel {delta}-Subunit
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 965 - 969.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Yamamura, S. Ugawa, T. Ueda, M. Nagao, and S. Shimada
Icilin Activates the {delta}-Subunit of the Human Epithelial Na+ Channel
Mol. Pharmacol., October 1, 2005; 68(4): 1142 - 1147.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ichimura, H. Yamamura, K. Sasamoto, Y. Tominaga, M. Taoka, K. Kakiuchi, T. Shinkawa, N. Takahashi, S. Shimada, and T. Isobe
14-3-3 Proteins Modulate the Expression of Epithelial Na+ Channels by Phosphorylation-dependent Interaction with Nedd4-2 Ubiquitin Ligase
J. Biol. Chem., April 1, 2005; 280(13): 13187 - 13194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.